Cardiology Service of Kazakhstan Today: Acute Coronary Syndrome, Chronic Heart Failure, Atherosclerosis

The article focuses on the prevalence of circulatory diseases, organization and implementation of new programs in the system of cardiological care services in the Republic of Kazakhstan. Currently, three key programs are functioning at the republican level: “Acute coronary syndrome”, “Chronic heart failure”, and “Atherosclerosis and dyslipoproteinemia”. The National Scientific Cardiac Surgery Center (Astana) is the coordinator of all these programs.

1. World Health Organisation. World health statistics 2019: monitoring health for the SDGs, sustainable development goals. [Internet] Available at: https://www.who.int/publications-detail-redirect/9789241565707

2. World Health Organisation. WHO reveals leading causes of death and disability worldwide: 2000-2019. [Internet] Available at: https://www.who.int/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019

3. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW et al. Heart Disease and Stroke Statistics – 2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254–743. DOI: 10.1161/CIR.0000000000000950

4. World Health Organisation. Cardiovascular diseases (CVDs). [Internet] Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

5. Kosherbaeva L., Samambaeva A., Boquete I.P., Imamatdinova A. Metho dology for calculation of avoidable mortality on the example of cardiovascular diseases in Kazakhstan. Science & Healthcare. 2022;24(4):101–7. DOI: 10.34689/SH.2022.24.4.013

6. Alieva AS, Tokgözoğlu L, Ray KK, Catapano AL. Lipid Clinics Network. Rationale and design of the EAS global project. Atherosclerosis Supplements. 2020;42:e6–8. DOI: 10.1016/j.atherosclerosissup.2021.01.002

7. Junusbekova G, Tundybayeva M, Akhtaeva N, Kosherbayeva L. Recent Trends in Cardiovascular Disease Mortality in Kazakhstan. Vascular Health and Risk Management. 2023;19:519–26. DOI: 10.2147/VHRM.S417693

8. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111–88. DOI: 10.1093/eurheartj/ehz455

9. Shakhanova A.T., Aukenov N.E., Nurtazina A.U., Shakhanov T.E., Masabaeva M.R., Apsalikov B.A. et al. Assessment of the frequency and nature of changes in the level of apolipoprotein B, lipid and carbohydrate metabolism in persons of Kazakh nationality. Astana Medical Journal. 2020;2(104):238–45.